Literature DB >> 22001698

Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.

Daniela Damjanovic1, Maziar Divangahi, Kapilan Kugathasan, Cherrie-Lee Small, Anna Zganiacz, Earl G Brown, Cory M Hogaboam, Jack Gauldie, Zhou Xing.   

Abstract

Lung immunopathology is the main cause of influenza-mediated morbidity and death, and much of its molecular mechanisms remain unclear. Whereas tumor necrosis factor-α (TNF-α) is traditionally considered a proinflammatory cytokine, its role in influenza immunopathology is unresolved. We have investigated this issue by using a model of acute H1N1 influenza infection established in wild-type and TNF-α-deficient mice and evaluated lung viral clearance, inflammatory responses, and immunopathology. Whereas TNF-α was up-regulated in the lung after influenza infection, it was not required for normal influenza viral clearance. However, TNF-α deficiency led not only to a greater extent of illness but also to heightened lung immunopathology and tissue remodeling. The severe lung immunopathology was associated with increased inflammatory cell infiltration, anti-influenza adaptive immune responses, and expression of cytokines such as monocyte chemoattractant protein-1 (MCP-1) and fibrotic growth factor, TGF-β1. Thus, in vivo neutralization of MCP-1 markedly attenuated lung immunopathology and blunted TGF-β1 production following influenza infection in these hosts. On the other hand, in vivo transgenic expression of MCP-1 worsened lung immunopathology following influenza infection in wild-type hosts. Thus, TNF-α is dispensable for influenza clearance; however, different from the traditional belief, this cytokine is critically required for negatively regulating the extent of lung immunopathology during acute influenza infection.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001698      PMCID: PMC3260802          DOI: 10.1016/j.ajpath.2011.09.003

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  71 in total

Review 1.  The role of Th17 cytokines in primary mucosal immunity.

Authors:  Jay K Kolls; Shabaana A Khader
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-20       Impact factor: 7.638

Review 2.  Signalling pathways of the TNF superfamily: a double-edged sword.

Authors:  Bharat B Aggarwal
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

Review 3.  Viral infection and aging as cofactors for the development of pulmonary fibrosis.

Authors:  Payal K Naik; Bethany B Moore
Journal:  Expert Rev Respir Med       Date:  2010-12       Impact factor: 3.772

4.  Radiographic study of severe Influenza-A (H1N1) disease in children.

Authors:  Cailei Zhao; Yungen Gan; Jie Sun
Journal:  Eur J Radiol       Date:  2010-10-20       Impact factor: 3.528

Review 5.  Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung.

Authors:  C Edward Rose; Sung-Sang J Sung; Shu Man Fu
Journal:  Microcirculation       Date:  2003-06       Impact factor: 2.628

6.  TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection.

Authors:  Anna Zganiacz; Michael Santosuosso; Jun Wang; Tony Yang; Lihao Chen; Maria Anzulovic; Scott Alexander; Brigitte Gicquel; Yonghong Wan; Jonathan Bramson; Mark Inman; Zhou Xing
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

7.  Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells.

Authors:  Stephen J Turner; Nicole L La Gruta; John Stambas; Gabriela Diaz; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

8.  CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis.

Authors:  Mehrnaz Gharaee-Kermani; Robert E McCullumsmith; Israel F Charo; Steven L Kunkel; Sem H Phan
Journal:  Cytokine       Date:  2003-12-21       Impact factor: 3.861

9.  Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice.

Authors:  Ichiro Inoshima; Kazuyoshi Kuwano; Naoki Hamada; Naoki Hagimoto; Michihiro Yoshimi; Takashige Maeyama; Akira Takeshita; Shiro Kitamoto; Kensuke Egashira; Nobuyuki Hara
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-05       Impact factor: 5.464

Review 10.  Anatomical features of anti-viral immunity in the respiratory tract.

Authors:  David L Woodland; Troy D Randall
Journal:  Semin Immunol       Date:  2004-06       Impact factor: 11.130

View more
  51 in total

1.  Influenza A (H1N1) virus infection triggers severe pulmonary inflammation in lupus-prone mice following viral clearance.

Authors:  Samantha R Slight-Webb; Harini Bagavant; Sherry R Crowe; Judith A James
Journal:  J Autoimmun       Date:  2015-01-03       Impact factor: 7.094

2.  Kinetic analysis of the immunity in a pregnant patient infected with avian influenza H7N9.

Authors:  Wei Qian; Peng-Cheng Jiang; Jun Qian; Zhao-Chen Jin; Jing Yang; Jiang Lin; Xiang-Mei Wen; Fang-An Han; Ling-Xiang Mao; Jing Yang; Zhao-Qun Deng
Journal:  Int J Clin Exp Med       Date:  2014-07-15

3.  Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ.

Authors:  Jessica M Breslow-Deckman; Cynthia M Mattingly; Susan E Birket; Samantha N Hoskins; Tam N Ho; Beth A Garvy; David J Feola
Journal:  J Immunol       Date:  2013-07-05       Impact factor: 5.422

4.  Direct IL-6 Signals Maximize Protective Secondary CD4 T Cell Responses against Influenza.

Authors:  Tara M Strutt; Karl Kai McKinstry; Yi Kuang; Caroline M Finn; Ji Hae Hwang; Kunal Dhume; Stewart Sell; Susan L Swain
Journal:  J Immunol       Date:  2016-09-19       Impact factor: 5.422

5.  Soluble, but not transmembrane, TNF-α is required during influenza infection to limit the magnitude of immune responses and the extent of immunopathology.

Authors:  Matthew P DeBerge; Kenneth H Ely; Richard I Enelow
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

6.  TNF deficiency dysregulates inflammatory cytokine production, leading to lung pathology and death during respiratory poxvirus infection.

Authors:  Ma Junaliah Tuazon Kels; Esther Ng; Zahrah Al Rumaih; Pratikshya Pandey; Sigrid R Ruuls; Heinrich Korner; Timothy P Newsome; Geeta Chaudhri; Gunasegaran Karupiah
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

7.  Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections.

Authors:  Olivia J Hall; Raffael Nachbagauer; Meghan S Vermillion; Ashley L Fink; Vanessa Phuong; Florian Krammer; Sabra L Klein
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

Review 8.  Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.

Authors:  K Kai McKinstry; Richard W Dutton; Susan L Swain; Tara M Strutt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-05-25       Impact factor: 4.291

Review 9.  The effector T cell response to influenza infection.

Authors:  Matthew M Hufford; Taeg S Kim; Jie Sun; Thomas J Braciale
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 10.  Multipronged CD4(+) T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus.

Authors:  Tara M Strutt; K Kai McKinstry; Nikki B Marshall; Allen M Vong; Richard W Dutton; Susan L Swain
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.